TY - JOUR
T1 - The active modulation of drug release by an ionic field effect transistor for an ultra-low power implantable nanofluidic system
AU - Bruno, Giacomo
AU - Canavese, Giancarlo
AU - Liu, Xuewu
AU - Filgueira, Carly S.
AU - Sacco, Adriano
AU - Demarchi, Danilo
AU - Ferrari, Mauro
AU - Grattoni, Alessandro
N1 - Publisher Copyright:
© 2016 The Royal Society of Chemistry.
PY - 2016/11/28
Y1 - 2016/11/28
N2 - We report an electro-nanofluidic membrane for tunable, ultra-low power drug delivery employing an ionic field effect transistor. Therapeutic release from a drug reservoir was successfully modulated, with high energy efficiency, by actively adjusting the surface charge of slit-nanochannels 50, 110, and 160 nm in size, by the polarization of a buried gate electrode and the consequent variation of the electrical double layer in the nanochannel. We demonstrated control over the transport of ionic species, including two relevant hypertension drugs, atenolol and perindopril, that could benefit from such modulation. By leveraging concentration-driven diffusion, we achieve a 2 to 3 order of magnitude reduction in power consumption as compared to other electrokinetic phenomena. The application of a small gate potential (±5 V) in close proximity (150 nm) of 50 nm nanochannels generated a sufficiently strong electric field, which doubled or blocked the ionic flux depending on the polarity of the voltage applied. These compelling findings can lead to next generation, more reliable, smaller, and longer lasting drug delivery implants with ultra-low power consumption.
AB - We report an electro-nanofluidic membrane for tunable, ultra-low power drug delivery employing an ionic field effect transistor. Therapeutic release from a drug reservoir was successfully modulated, with high energy efficiency, by actively adjusting the surface charge of slit-nanochannels 50, 110, and 160 nm in size, by the polarization of a buried gate electrode and the consequent variation of the electrical double layer in the nanochannel. We demonstrated control over the transport of ionic species, including two relevant hypertension drugs, atenolol and perindopril, that could benefit from such modulation. By leveraging concentration-driven diffusion, we achieve a 2 to 3 order of magnitude reduction in power consumption as compared to other electrokinetic phenomena. The application of a small gate potential (±5 V) in close proximity (150 nm) of 50 nm nanochannels generated a sufficiently strong electric field, which doubled or blocked the ionic flux depending on the polarity of the voltage applied. These compelling findings can lead to next generation, more reliable, smaller, and longer lasting drug delivery implants with ultra-low power consumption.
UR - http://www.scopus.com/inward/record.url?scp=84995449821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995449821&partnerID=8YFLogxK
U2 - 10.1039/c6nr06235k
DO - 10.1039/c6nr06235k
M3 - Article
AN - SCOPUS:84995449821
SN - 2040-3364
VL - 8
SP - 18718
EP - 18725
JO - Nanoscale
JF - Nanoscale
IS - 44
ER -